Indianapolis pharmacy recalls compounded drugs

(AP)—A pharmacy that makes specialty medications is recalling nearly 100 compounded drugs after federal regulators found potential safety problems during an inspection.

Nora Apothecary Alternative Therapies of Indianapolis says it is recalling all sterile drugs that have not reached their expiration date. The drugs were made on or before April 19.

The company said it initiated the recall after the found quality control problems that threaten the of its products. If compounded drugs are not sterile they can cause infections, though the company said it has not received any reports of illness.

The FDA is conducting a wave of inspections at compounding pharmacies across the country. The action follows a deadly last year caused by contaminated drugs from a Massachusetts compounding pharmacy.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA cites sanitary issues at specialty pharmacies

Apr 12, 2013

(AP)—The Food and Drug Administration says it has uncovered troubling sterility problems at 30 specialty pharmacies that were inspected following a recent outbreak of meningitis caused by contaminated drugs.

FDA: Georgia pharmacy recalling all sterile drugs

Mar 21, 2013

(AP)—The Food and Drug Administration says a Georgia compounding pharmacy that distributed a drug linked to eye infections is now recalling all of its injectable medicines following a federal inspection.

Fla. compounding pharmacy recalls sterile drugs

Apr 21, 2013

A Florida-based compounding pharmacy is voluntarily recalling all lots of its sterile non-expired drug products sold nationwide over concerns the products are not sterile and may contain bacteria.

FDA finds contamination concerns at Ameridose

Nov 12, 2012

(AP)—Federal health inspectors have found more than a dozen sterility problems, including insects, at a drugmaking facility with the same founders as the specialty pharmacy linked to a deadly meningitis outbreak.

Recommended for you

Supercomputers link proteins to drug side effects

3 hours ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

11 hours ago

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments